EA201001558A1 - КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА - Google Patents

КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА

Info

Publication number
EA201001558A1
EA201001558A1 EA201001558A EA201001558A EA201001558A1 EA 201001558 A1 EA201001558 A1 EA 201001558A1 EA 201001558 A EA201001558 A EA 201001558A EA 201001558 A EA201001558 A EA 201001558A EA 201001558 A1 EA201001558 A1 EA 201001558A1
Authority
EA
Eurasian Patent Office
Prior art keywords
arnox
natural
tazetta
anr
oxygen
Prior art date
Application number
EA201001558A
Other languages
English (en)
Inventor
Дейл Керн
Кристиан Мэдоуз
Original Assignee
Ню Скин Интернэшнл, Инк.
Нокс Текнолоджиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ню Скин Интернэшнл, Инк., Нокс Текнолоджиз, Инк. filed Critical Ню Скин Интернэшнл, Инк.
Publication of EA201001558A1 publication Critical patent/EA201001558A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение относится к средствам для блокирования сывороточных факторов старения и методам их применения. Конкретнее, изобретение относится к веществам, которые называются здесь "нарактин" для обозначения любого одного из нескольких природных ингибиторов arNOX, присутствующих в порошке N.Tazetta (нарцисс) или способных усилить порошок N. tazetta до уровня ингибирования, соизмеримого со свежими экстрактами N. tazetta, и способам применения "нарактинов" для предотвращения или лечения расстройств и осложнений расстройств, возникающих в результате повреждения клеток, вызванного связанной со старением изоформой NADH оксидазы (arNOX). В одном варианте осуществления вещества изобретения включают по меньшей мере один природный нарактин. К тому же такие природные нарактины способны увеличить анти-arNOX эффект других природных веществ, ингибирующих arNOX.
EA201001558A 2008-03-28 2008-03-28 КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА EA201001558A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058683 WO2009120214A1 (en) 2008-03-28 2008-03-28 Compositions comprising anrnox-inhibitors for the inhibition of reactive oxygen species

Publications (1)

Publication Number Publication Date
EA201001558A1 true EA201001558A1 (ru) 2011-06-30

Family

ID=40056186

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001558A EA201001558A1 (ru) 2008-03-28 2008-03-28 КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА

Country Status (11)

Country Link
EP (1) EP2280714A1 (ru)
JP (1) JP2011515466A (ru)
KR (1) KR20110000745A (ru)
CN (1) CN102014930A (ru)
AU (1) AU2008353441A1 (ru)
CA (1) CA2719833A1 (ru)
EA (1) EA201001558A1 (ru)
IL (1) IL208324A0 (ru)
MX (1) MX2010010668A (ru)
WO (1) WO2009120214A1 (ru)
ZA (1) ZA201007247B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699726C2 (ru) * 2013-01-03 2019-09-09 Юниверсите Де Бордо Селективные ингибиторные пептиды nox-1 и их применение

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181121B1 (en) * 2010-12-03 2020-10-28 EPI Health, LLC Pharmaceutical cream compositions comprising oxymetazoline to treat rosacea
CA2822328A1 (en) * 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of dynein in skin
CN102440927B (zh) * 2011-02-10 2012-11-21 漳州市格莱雅化妆品有限公司 一种水仙花美白爽肤水化妆品
CN102641223A (zh) * 2011-02-18 2012-08-22 株式会社爱茉莉太平洋 用于改善肤色或增加皮肤弹性的化妆品组合物
CN102526160B (zh) * 2012-01-31 2015-08-12 王玉石 外用于人体皮肤的组合物及其用途
US9125843B2 (en) 2013-10-03 2015-09-08 Elc Management Llc Methods and compositions for improving the appearance of skin
JP6698358B2 (ja) * 2015-03-12 2020-05-27 Ｓｈｉｏｄａライフサイエンス株式会社 汗分泌促進剤及び該汗分泌促進剤を含有するドライスキンの予防薬又は治療薬
KR102309958B1 (ko) * 2015-03-24 2021-10-07 주식회사 엘지생활건강 구근추출물을 포함하는 피부 개선용 조성물
US9750682B2 (en) 2015-07-30 2017-09-05 Elc Management, Llc Methods and compositions for improving the appearance of skin
CN105581364B (zh) * 2016-03-07 2017-07-07 云南瑞升烟草技术（集团）有限公司 一种用于卷烟烟丝中的虾青素微胶囊的制备方法及应用
JP6912771B2 (ja) * 2017-04-11 2021-08-04 学校法人立命館 脂漏性角化症の予防又は改善剤
US10251832B2 (en) 2017-05-26 2019-04-09 Mary Kay Inc. Cosmetic compositions and methods
CN107927779A (zh) * 2017-11-27 2018-04-20 爱可道生物科技有限公司 一种美容养颜口服液及其制备方法
WO2021091284A2 (ko) * 2019-11-06 2021-05-14 한국생명공학연구원 비버눔 스텔라토토멘토섬 추출물을 포함하는 피부 노화 방지 및 피부 주름 개선용 화장료 조성물
CN115721772B (zh) * 2022-12-15 2024-05-10 湖南中腾湘岳生物科技有限公司 一种可吸收止血材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559328A (en) * 1984-06-21 1985-12-17 Warner-Lambert Company Non-steroidal anti-inflammatory compounds to treat inflammation
LU87408A1 (fr) * 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
AU3073692A (en) * 1991-11-25 1993-06-28 Richardson-Vicks Inc. Compositions for regulating skin wrinkles and/or skin atrophy
EP0958810B1 (en) * 1991-11-25 2003-05-02 Richardson-Vicks Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
JPH1180002A (ja) * 1997-09-12 1999-03-23 Noevir Co Ltd 老化防止用皮膚外用剤
FR2782269B1 (fr) * 1998-08-17 2001-08-31 Oreal Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
JP2006510569A (ja) * 2001-12-28 2006-03-30 メディクエスト セラピューティックス インク 局所皮膚淡色化剤用メラノサイトチロシナーゼ阻害剤としてのヒドロキサム酸およびその誘導体
US20050226947A1 (en) * 2004-02-04 2005-10-13 Dale Kern Agents for sequestering serum aging factors and uses therefore
US20060275229A1 (en) * 2005-05-17 2006-12-07 Sreekumar Pillai Skin care active complex and methods of using same
WO2007118605A1 (en) * 2006-04-18 2007-10-25 Dsm Ip Assets B.V. Cosmetic compositions comprising salicylic acid and ascorbic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699726C2 (ru) * 2013-01-03 2019-09-09 Юниверсите Де Бордо Селективные ингибиторные пептиды nox-1 и их применение

Also Published As

Publication number Publication date
AU2008353441A2 (en) 2010-11-25
CA2719833A1 (en) 2009-10-01
ZA201007247B (en) 2011-12-28
JP2011515466A (ja) 2011-05-19
AU2008353441A1 (en) 2009-10-01
KR20110000745A (ko) 2011-01-05
IL208324A0 (en) 2010-12-30
WO2009120214A1 (en) 2009-10-01
CN102014930A (zh) 2011-04-13
MX2010010668A (es) 2011-04-26
EP2280714A1 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
EA201001558A1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ anr NOX-ИНГИБИТОРЫ ДЛЯ ПОДАВЛЕНИЯ АКТИВНЫХ ФОРМ КИСЛОРОДА
WO2007072179A3 (en) Histone deacetylase inhibitors for enhancing activity of antifungal agents
EA201491008A1 (ru) Комбинация антагониста crth2 и ингибитора протонного насоса для лечения эозинофильного эзофагита
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
EA201100440A1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
WO2012037155A3 (en) Tyrosine kinase inhibitors
CR20150491A (es) 3-pirimidin-4-il oxazolidin -2- onas como inhibidores de idh mutante
EA200900360A1 (ru) Новые низкомолекулярные ингибиторы mdm2 и их применение
EA201270184A1 (ru) Лечение расстройств печени ингибиторами pi3k
EA201100119A1 (ru) Химические соединения 251
BR112012032193A2 (pt) composto, composiçoes e métodos de uso de feniltioacetato
EA201171396A1 (ru) Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата
WO2007090068A3 (en) Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
ATE549336T1 (de) Heteroarylverbindungen,zusammensetzungen daraus und ihre verwendung als proteinkinasehemmer
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
UA98297C2 (en) Triazolopyridazines as tyrosine kinase modulators
MA32393B1 (fr) Composés et compositions servant d'inhibiteurs de kinases
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
EA201500769A1 (ru) Ингибиторы е1 активирующих ферментов
WO2007051065A3 (en) Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
WO2012058645A8 (en) Heterocyclic tyrosine kinase inhibitors
EA200601766A1 (ru) Производные имидазола
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы